Are Wall Street Analysts Bullish on Cognizant Stock?
📊 Cognizant Technology Solutions (CTSH) has a market cap of $26.2 billion and operates globally through segments including Financial Services, Health Sciences, and Communications.
📉 Shares have underperformed the broader market recently, dropping 25.4% over the past year compared to the S&P 500's 28.3% gain.
🤖 Despite a recent uptick in 2026, CTSH still trailed the S&P 500 index, which rose 4.2% while CTSH climbed only 2.8%.
💹 Technology sector ETF (XLK) significantly outperformed CTSH, rising 52.2% last year and 10.5% in 2026.
📈 Q1 2026 earnings saw revenue of $5.4 billion exceed analyst estimates, with adjusted EPS of $1.40 also beating expectations.
🔮 For the fiscal year ending in June, CTSH expects revenue between $5.45 billion and $5.52 billion.
📅 Full-year analysts project earnings per share to increase 7.1% to $5.65 on a diluted basis.
✅ The company has beaten consensus estimates for four consecutive quarters, indicating a solid earnings surprise history.
👥 Of the 27 analysts covering the stock, the consensus rating is "Moderate Buy," supported by ten "Strong Buy" ratings and one "Moderate Buy."
🗣️ Analyst sentiment has shifted slightly more bullish recently, though some hold positions remain unchanged.
💼 On April 28, JP Morgan analyst Tien-Tsin Huang maintained an "Overweight" rating but lowered the price target from $92 to $74.
🎯 The mean analyst price target of $80.59 represents a potential 47.3% upside from current market prices.
🚀 The Street-high price target of $107 suggests a robust 95.6% upside potential from current levels.
⚠️ Investors should note that not all analysts agree, with 16 of the 27 holding a "Hold" rating.
⏳ While short-term performance lags, long-term outlooks remain mixed between moderate buy and hold classifications.
- Cognizant delivered strong Q1 2026 earnings, with revenue of $5.4 billion surpassing Wall Street estimates.
- Adjusted EPS reached $1.40, beating analyst expectations and reinforcing a track record of positive surprises in each of the last four quarters.
- Analysts project EPS to rise 7.1% year-over-year to $5.65 on a diluted basis for the fiscal year ending in December.
- The stock holds a consensus 'Moderate Buy' rating from 27 analysts, supported by 10 'Strong Buy' ratings.
- A recent mean price target of $80.59 suggests substantial upside potential, with a Street-high target of $107 indicating over 95% upside from current levels.
- JP Morgan analyst Tien-Tsin Huang maintained an 'Overweight' rating for CTSH as of Apr. 28.
- CTSH shares have significantly underperformed the broader market, declining 25.4% over the past year compared to the S&P 500's 28.3% surge.
- Even in 2026, the stock has only climbed nearly 2.8%, trailing the SPX's rise of 4.2%.
- While individual analysts suggest upside, a large portion of Wall Street coverage remains neutral, with 16 'Holds' out of 27 analysts covering CTSH.
- JP Morgan analyst Tien-Tsin Huang lowered its price target from $92 to $74 on Apr. 28, indicating reduced valuation expectations despite maintaining an 'Overweight' rating.
- CTSH shares declined marginally in the last trading session following the release of its Q1 2026 earnings, despite beating estimates for revenue and adjusted EPS.